THE USE OF HEMATOPOIETIC GROWTH-FACTORS TO SUPPORT CYTOTOXIC CHEMOTHERAPY FOR PATIENTS WITH BREAST-CANCER

被引：3
作者：
DEMETRI, GD [1 ]
机构：
[1] HARVARD UNIV, SCH MED, DANA FARBER CANC INST, DEPT MED, 44 BINNEY ST, BOSTON, MA 02115 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1994年 / 8卷 / 01期
关键词：
D O I：
10.1016/S0889-8588(18)30198-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：233 / 249
页数：17
相关论文
共 74 条
[1]  
ABE O, 1992, LANCET, V339, P71
[2]  
ABELS RI, 1991, BLOOD CELL GROWTH FA
[3]  
ANDREWS RG, 1991, BLOOD, V78, P1975
[4]   EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].
ANTMAN, KS ;
GRIFFIN, JD ;
ELIAS, A ;
SOCINSKI, MA ;
RYAN, L ;
CANNISTRA, SA ;
OETTE, D ;
WHITLEY, M ;
FREI, E ;
SCHNIPPER, LE .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598
[5]  
BEUTLER E, 1993, BLOOD, V81, P1411
[6]  
BIESMA B, 1992, BLOOD, V80, P1141
[7]   QUANTITATIVE RELATIONSHIPS BETWEEN CIRCULATING LEUKOCYTES AND INFECTION IN PATIENTS WITH ACUTE LEUKEMIA [J].
BODEY, GP ;
BUCKLEY, M ;
SATHE, YS ;
FREIREICH, EJ .
ANNALS OF INTERNAL MEDICINE, 1966, 64 (02) :328-+
[8]   THE USE OF GRANULOCYTE COLONY-STIMULATING FACTOR TO INCREASE THE INTENSITY OF TREATMENT WITH DOXORUBICIN IN PATIENTS WITH ADVANCED BREAST AND OVARIAN-CANCER [J].
BRONCHUD, MH ;
HOWELL, A ;
CROWTHER, D ;
HOPWOOD, P ;
SOUZA, L ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1989, 60 (01) :121-125
[9]   PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER [J].
BRONCHUD, MH ;
SCARFFE, JH ;
THATCHER, N ;
CROWTHER, D ;
SOUZA, LM ;
ALTON, NK ;
TESTA, NG ;
DEXTER, TM .
BRITISH JOURNAL OF CANCER, 1987, 56 (06) :809-813
[10]   SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOLLOWING STANDARD-DOSE COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN [J].
BRUGGER, W ;
FRISCH, J ;
SCHULZ, G ;
PRESSLER, K ;
MERTELSMANN, R ;
KANZ, L .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) :1452-1459
12345678